Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1660 S Columbian Way # S-112
Seattle, WA 98108Phone+1 206-768-5287- Is this information wrong?
Summary
- Peter Wu, MD, FACS is a fellowship-trained surgical oncologist at the VA Puget Sound, Director of the VISN20 TeleTumor Board Program, Washington State Chair for the American College of Surgeons Commission on Cancer, Director of the Department of Surgery Harkins Symposium, member of the Diversity Equity and Inclusion Council, Committee Chair of the former UW Medical Student Research Training Program, and a UW Associate Professor of Surgery.
Dr. Wu has clinical expertise in the management of tumors of the upper and lower GI tract with research interests in esophageal and rectal cancers; neuroendocrine tumors, pancreatic cancer, melanoma, retroperitoneal sarcoma, and breast cancer. Dr. Wu has led the regional VA TeleTumor Board and expanded its capabilities to include telepathology. To honor those that
have served, he strives to provide Veterans with efficient personalized comprehensive cancer care in a multidisciplinary environment and support the educational mission of the profession and institution. He maintains a translational laboratory at the VA Puget Sound with an interest treating advanced gastrointestinal malignancies and seeking a better understanding what causes tumor cells to "escape" cell death and enter senescence pathways following cancer treatment. He is a principal investigator for a VA Gastrointestinal Tumor Tissue and Blood Repository and his research funding has supported studies into molecular pathways of therapy-induced senescence, identify novel tumor-specific senescence biomarkers to predict treatment response, and reveal key checkpoints that could be targeted to block senescence escape and potentiate clinical treatment response. He has also been the institutional PI responsible for SWOG clinical trials conducted at the VA Puget Sound as well as other investigator-initiated studies.
Education & Training
- University of ChicagoFellowship, Complex General Surgical Oncology, 2001 - 2004
- University of ConnecticutResidency, Surgery, 1993 - 2001
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
- University of PennsylvaniaBSE, Chemical Engineering, 1983 - 1987
Certifications & Licensure
- WA State Medical License 2005 - 2025
- IL State Medical License 2001 - 2005
- MD State Medical License 1995 - 1999
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Mid-Size Health System / Patient Support Team of the Year Award American Cancer Society, 2023
- Academic Hall of Fame Induction West Jefferson Hills School District (Pittsburgh, PA), 2023
- State Chair Outstanding Performance Award American College of Surgeons Commission on Cancer, 2021
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsHuman mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequencesHarvey I. Pass, Jessica S. Donington, Peter Wu, Paola Rizzo, Michael Nishimura, Ronald C. Kennedy, Michele Carbone> ;The Journal of Thoracic and Cardiovascular Surgery. 1998 Nov 1
- 3 citationsFurther validation of SV40-like DNA in human pleural mesotheliomas.Harvey I. Pass, Paola Rizzo, Jessica S. Donington, P. Wu, Michele Carbone> ;Developments in Biological Standardization. 1998 Jan 1
- 41 citationsAccelerated cellular senescence in solid tumor therapy.P C Wu, Q Wang, L Grobman, E Chu, D Y Wu> ;Experimental Oncology. 2012 Oct 1
- Join now to see all
Journal Articles
- Management of Unsuspected Gallbladder Cancer in the Era of Minimally Invasive SurgeryWolf P, Bhargava P, Pellegrini C, Wu PC, J Cancer Therapy, 7/11/2010
Books/Book Chapters
Other
- NCDB: A Growing Valuable ResourceWu PC
https://coc100.facs.org/index/ncdb-journal-article-reviews/
American College of Surgeons Commission on Cancer, CoC 100th Anniversary - 2021
Committees
- WA State Chair, American College of Surgeons Commission on Cancer
- Scientific Committee/Surgery Permanent Member, OESO (World Organization for Specialized Studies on the Diseases of the Esophagus)
- Disparities Committee, Society of Surgical Oncology
- Curriculum Content Subcommittee, American College of Surgeons
- Research Committee, Association of VA Surgeons
- Director, V20 Cancer Telemedicine Program
- Scholarship Subcommittee, University of Washington School of Medicine
- Medical Student Research Training Program Chair, University of Washington School of Medicine
- GI Oncology Program Member, Fred Hutchinson/UW Cancer Consortium
Research History
- PIHis research group studies the molecular mechanisms of therapy-induced senescence, identify novel tumor-specific senescence biomarkers to detect occult disease and predict treatment response, and discover checkpoints that could be targeted to block senescence.2005 - Present
Professional Memberships
- Member
- Member
- Member
- Association of VA SurgeonsMember
- World Organization for Specialized Studies on the Diseases of the Esophagus.Member
Hospital Affiliations
- Seattle VA Medical CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: